|
RALGAPB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.510210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.501600E-01 |
| Normal-vs-Stage2 |
5.058600E-01 |
| Normal-vs-Stage3 |
7.153900E-02 |
| Normal-vs-Stage4 |
2.576600E-01 |
| Stage1-vs-Stage2 |
8.503200E-01 |
| Stage1-vs-Stage3 |
2.828800E-01 |
| Stage1-vs-Stage4 |
7.265000E-01 |
| Stage2-vs-Stage3 |
3.446600E-01 |
| Stage2-vs-Stage4 |
6.662200E-01 |
| Stage3-vs-Stage4 |
6.684800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.170620E-01 |
| Normal-vs-AfricanAmerican |
9.109400E-01 |
| Normal-vs-Asian |
2.795800E-01 |
| Caucasian-vs-AfricanAmerican |
2.926200E-01 |
| Caucasian-vs-Asian |
9.616200E-01 |
| AfricanAmerican-vs-Asian |
3.715600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.769000E-01 |
| Normal-vs-Female |
1.892550E-01 |
| Male-vs-Female |
7.173800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.120400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.326500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.419400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.537650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.042000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.016800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.250010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.091800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.799200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.045200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.384200E-01 |
| Classical-VS-Follicular |
1.523950E-02 |
| Classical-VS-Other |
1.324390E-01 |
| Classical-VS-Normal |
7.501400E-01 |
| Tall-VS-Follicular |
9.300200E-01 |
| Tall-VS-Other |
4.210600E-01 |
| Tall-VS-Normal |
9.515600E-02 |
| Follicular-VS-Other |
4.884800E-01 |
| Follicular-VS-Normal |
4.006300E-02 |
| Other-VS-Normal |
6.862400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.842300E-02 |
| Normal-vs-N1 |
2.037800E-01 |
| N0-vs-N1 |
8.319400E-01 |
|
|
